Trial intelligence / Profile preview

Bicitra versus Polycitra for pediatric urolithiasis

IRCT20190619043945N1Phase 3Completed

Sponsor
Qom University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of trisodium citrate in Lithiasis (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Prevent stone enlargement, Prevention of renal failure and 1 more. Started Apr 2020; status: completed.

02

Drugs

trisodium citrate
03

Conditions

Lithiasis

Beyond the preview

Go deeper on IRCT20190619043945N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190619043945N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call